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a b s t r a c t
Olfaction plays an important role in emotions in our daily life. Pleasant odors are known to evoke
positive emotions, inducing relaxation and calmness. The beneﬁcial effects of vanillin on depressive
model rats were investigated using a combination of behavioral assessments and neurotransmitter
measurements. Before and after chronic stress condition (or olfactory bulbectomy), and at the end of
vanillin or ﬂuoxetine treatment, body weight, immobility time on the forced swimming test and sucrose
consumption in the sucrose consumption test were measured. Changes in these assessments revealed
the characteristic phenotypes of depression in rats. Neurotransmitters were measured using ultrahigh-
performance liquid chromatography. Our results indicated that vanillin could alleviate depressive
symptoms in the rat model of chronic depression via the olfactory pathway. Preliminary analysis of
the monoamine neurotransmitters revealed that vanillin elevated both serotonin and dopamine levels in
brain tissue. These results provide important mechanistic insights into the protective effect of vanillin
against chronic depressive disorder via olfactory pathway. This suggests that vanillin may be a potential
pharmacological agent for the treatment of major depressive disorder.
& 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Major depressive disorder (MDD) is a neuropsychiatric disorder
characterized by persistent despondent state accompanied by low
self-esteem and a loss of interest or pleasure in normally enjoyable
activities (anhedonia). It is a highly prevalent, multifactorial
disorder with high disability and mortality rates (Zalsman et al.,
2006). The psychosocial difﬁculties lead to serious physical, mental
and socioeconomic consequences, such as impairments in social
communication and vocational function. Many sufferers do not
live independently. Half of patients attempt suicide at least once
and up to 20% ultimately commit suicide (Pompili et al., 2009).
Almost all of them need long-term medication and so research
into pharmacotherapy of MDD has evolved over the centuries.
Some powerful antidepressants have made indelible contribu-
tions, such as selective serotonin reuptake inhibitor (SSRIs),
tricyclic antidepressant (TCA), and monoamine oxidase (MAO)
inhibitors. However, some of them are of variable effectiveness
and some exert undesirable side effects (Xu et al., 2005). There-
fore, the development of alternative antidepressants is still the
ideal aim pursued by researchers. Olfaction is an important
function for animals, playing roles in food hunting, sexual beha-
vior, aggression, territorial defense, identiﬁcation, and among
others (Thiessen and Rice, 1976). The olfactory centers include
the prepyriform cortex, amygdala, hypothalamus, hippocampus
and other limbic system structures (Benignus and Prah, 1982).
Interestingly, a number of these regions also play important roles
in emotion processing and this overlap explains the high level of
functional connectivity between odor and emotions. This has
made olfactory stimulation a promising method for mood induc-
tion (Zald and Pardo, 1997; Rolls, 2004; Royet et al., 2003). Vanillin,
a single molecule, extracted from vanilla beans, is a popular odor
used widely in perfume, food and medicine (Ho et al., 2009, 2011).
It has even been used by injection, at an effective dose amount, to
calm or sedate patients (Abraham et al., 1997). As an odorant,
vanillin is generally rated as pleasant and correspondingly evokes
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positive moods (Seubert et al., 2009). This makes vanillin a
promising aroma for modulating emotions.
On the basis of the close anatomic and physiological link
between olfaction and emotions, we hypothesized that odorants
with strong hedonic qualities, such as vanillin, could evoke
happiness and modulate emotions in MDD. The aim of the present
study was to assess the inﬂuence of vanillin on depression-like
behaviors in rats. Additionally, to elucidate the possible underlying
mechanisms, a quantitative analysis of monoamine neurotrans-
mitters in the brain was performed using ultrahigh-performance
liquid chromatography (UPLC).
2. Materials and methods
2.1. Animals
Male Sprague-Dawley rats (200–250 g) were obtained from the Department of
Laboratory Animal Science, Anhui Medical University (Hefei, China). The animals
were housed individually under standard colony conditions, with a 12 h light/dark
cycle and ad libitum food and water. They were allowed to acclimatize to the colony
for at least 7 days before any experimentation. All experimental manipulations
were carried out during the light phase of the light/dark cycle.
All experimental procedures were performed in compliance with the Animal
Scientiﬁc Procedures Act of revised directive of 2010/63/EU on the protection of
animals used for scientiﬁc purpose and received local ethics committee approval
(number: LLSC2013006). All efforts were made to minimize the number of animals
used and their suffering.
2.2. Animal model
Two models of depressive disorder were used to assess the effects of vanillin in
rats. The chronic depressive disorder model was induced by chronic unpredictable
mild stress (CUMS), and the acute depressive disorder model was induced by
olfactory bulbectomy which disrupted the olfactory pathway (Jesberger and
Richardson, 1988). The experimental protocol is shown in Fig. 1. Here, pre-model
is deﬁned as the parameters measured before modeling (CUMS or olfactory
bulbectomy) and post-model is deﬁned as the parameters observed after modeling.
By analogy, the principle is also applied to pre-CUMS, post-CUMS, pre-operation
and post-operation.
2.2.1. CUMS procedure
Stressors were administered once daily between 08:30 and 10:30 h, with the
exception of the 24 h duration stressors. The CUMS procedure was revised from the
reference (Wu et al., 2007). Stressors consisted of (1) 5 min warm swim at 42 1C;
(2) 24 h wet litter;(3) 24 h food deprivation; (4) 90 s tail pinch; (5) 24 h water
deprivation; (6) 5 min cold swim at 4 1C, after which they were toweled dry;
(7) 24 h cage tilt (cages were tilted to 451 from the horizontal). The stressors were
distributed randomly with intervals of at least 7 days. All stressors were adminis-
tered four times within 4 weeks.
After the procedure, the animals were divided into three groups with 8–10 rats per
group: the stressþﬂuoxetine group; the stressþvanillin aromatherapy group and the
stress (untreated) group.
2.2.2. Olfactory bulbectomy
In order to investigate the pathway by which vanillin worked, another two groups
(10 rats per group) were added: the bulbectomyþvanillin group and the control
group (sham). Olfactory bulbectomy was performed as described previously (Jaako-
Movits et al., 2006). Animals were deeply anesthetized with 10% chloral hydrate
(330 ml/100 g body weight, i.p.). The head hair was shaved and swabbed with
antiseptic, after which the animal was placed under a stereotaxic instrument and a
midline frontal incision was made in the scalp, with the skin being retracted
bilaterally. The surgical procedure involved drilling two burr holes on either side
1 mm from the midline of the frontal bone coving the olfactory bulbs. The bulbs were
aspirated. The cavity was packed with surgical foam and the skin was closed with
surgical sutures. The animals were allowed to recover by warming to maintain body
temperature. Rats in the sham surgery condition received burr holes only. The
completeness of olfactory bulb removal was veriﬁed upon sacriﬁce. After surgery the
animals were housed individually for 2 weeks of recovery. Before operation and after
recovery, the animals underwent stress hormone determination and behavioral
assessments to conﬁrm the validity of olfactory bulbectomy-induced depressive
disorder model. The bulbectomyþvanillin group was treated as the stressþvanillin
group and the control group was treated as the stress group.
2.3. Pharmacological treatment
For the stressþﬂuoxetine group, the animals were administered a daily oral
dose (10 mg/kg/d, diluted in distilled water) of the SSRI ﬂuoxetine (Eli Lilly &Co.,
Souzhou, China) each morning. For the stressþvanillin group and the bulbecto-
myþvanillin group, vanillin (Sangon Biotech, Shanghai co., Ltd, China) was
administrated in a Plexiglas cylinder 50 cm tall and 35 cm diameter with two
layers separated by a porous Plexiglas board. The rat still in its cage was gently
placed on the upper layer, and 5 ml of 600 mg/l vanillin (in distilled water) sprayed
on to the ﬂoor of the lower layer (Atanasova et al., 2012). The odor of vanillin would
pervade to the upper layer through the porous board where the rat received
vanillin aromatherapy for 1/2h at 8 hourly intervals. Rats in the stress and the
control groups received similar handling to the stressþvanillin group, but without
any odor administrated.
2.4. Body weight
The effect of the stress and treatment on body weight was measured by
electronic balance and recorded at ﬁxed time points. This is a diagnostic criterion
for depressive disorder with accompanying weight loss or weight gain (Nestler et
al., 2002).
2.5. Tail Blood corticosterone determination
Corticosterone is an important stress hormone in animals and has signiﬁcant
activities as glucocorticoid involved in MDD. When elevated it reveals chronic
stress and so provides an endocrinological diagnostic criterion for depressive
disorder in animal models. For CUMS-induced depressive disorder model, serum
corticosterone was determined before the CUMS procedure and next day after the
CUMS procedure. For olfactory bulbectomy-induced depressive disorder model,
serum corticosterone was determined before the operation and 14 days after the
operation. In both models, blood was drawn from the tail vein of anesthetized rats
at 9:30 -11:00 a.m. of the day, which was 1 day ahead of other behavioral
assessments. The blood was centrifuged at 3000 rpm for 10 min at 4 1C (Eppendorf,
5810R).The clear serum was extracted(about 0.5 ml) and sent to the endocrinology
center of the First Afﬁliated Hospital of Anhui Medical University where serum
corticosterone concentration was determined by chemiluminescence detection
(ADVIA centaur immunoassay system, Siemens, German).
2.6. Behavioral assessments
Before and after CUMS (or operation), and at the end of administration,
immobility time in the forced swimming test (FST) and the sucrose consumption
in the sucrose consumption test (SCT) were measured. Changes in these parameters
reﬂected the behavioral characteristic phenotypes of depression in rats.
2.6.1. FST
The FST is a procedure in which rats are forced to swim for 6 min. This
parameter was performed as described previously (Porsolt et al., 1978). The rat was
placed individually in a Plexiglas cylinder 50 cm tall, 20 cm diameter ﬁlled to
4071.5 cm with 2470.5 1C water from which escape was impossible. Fifteen
minutes later, the rat was removed and dried before being returned to its home
cage. Fresh water was used for each rat and the cylinder was also cleaned between
trials. After 24 h, the animals were returned to the cylinders and the procedure was
repeated for another 6 min. Immobility time was recorded for 2–6 min by video
camera through the side of the cylinder, which was illuminated from the opposite
side. An experimenter monitored the video camera unaware of the treatment
Fig. 1. Overall ﬂow of methodology used for studying the effects of vanillin on:
(1) CUMS induced animal model; and (2) olfactory bulbectomy-induced animal
model. ▲: Determination of serum corticosterone from tail blood, 1 day ahead of
behavioral assessments; Δ: Assessments of depression-like behaviors at different
time points.
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received by the animals. Immobility was deﬁned as the lack of motion of the whole
body, except for small movements necessary to keep the animal's head above the
water. This indicates learned helpless and it is one of the core diagnostic criteria,
increasing with the severity of the condition.
2.6.2. SCT
The SCT was described by Papp et al. (1991) as a measure of hedonic behavior. It is
one of the core diagnostic criteria for depressive disorder with a decrease in the volume
of sucrose consumed indicating a depressed state. Sucrose intake was introduced at
weekly intervals during the CUMS procedure. After a 24 h period of water deprivation,
the SCT was performed in the home cage. Animals were given a 1% sucrose solution and
after 24 h, the consumption of sucrose was measured by weighing the bottles.
2.7. Neurotransmitter analyses
At the end of the experiment, the rats were deeply anesthetized with chloral
hydrate and decapitated. Their brains were rapidly removed from the skull. The
blood vessels and the soft cerebral covering were removed carefully from the brain
before being frozen on dry ice. They were then weighed, homogenized with an
Ultrasonic Turax T25 (Bio-block Scientiﬁc, France) in 1PBS (10 mlPBS/g brain
tissue). They were then centrifuged at 10,000 rmp for10 min at 4 1C. The super-
natants were kept at 80 1C until quantiﬁcation of monoamine neurotransmitter
levels and the total soluble protein were performed.
The dopamine (DA), norepinephrine (NE) and serotonin (5-HT) levels were
determined by UPLC with ﬂuorescence detection (Acquity UPLC BEH C18 1.7 mm,
Waters, USA) according to a previously described HPLC procedure for measuring
monoamine neurotransmitters (Sa et al., 2012; Zhao et al., 2011)(see Fig. S1 and S2).
Unlike the HPLC procedure, the ﬂow rate was set at 0.3 ml/min and the injection
volume was 5 ml. The detailed information about the UPLC procedure was well
documented in the supplemental data. The linear equations, linear ranges and
detection limits of monoamine neurotransmitters were given as Table S1.
The total soluble protein in supernatants was used as the internal reference
standard for the quantiﬁcation of monoamine neurotransmitters. It was detected
by improved concentration BCA protein assay kits (Sangon Biotech, Shanghai Co.,
Ltd, China) (see Table S2).
2.8. Data analysis
Data were expressed as the mean7S.E.M (standard error of the mean). Data
were analyzed using Spss11.5 software using repeated measures of analysis of
variance (ANOVA) by post-hoc test for the parameters within the same group and
one-way ANOVA followed by least signiﬁcant difference test for the parameters
among the different groups (two-tailed). In all instance, Po0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Body weight and serum corticosterone
After stress condition, body weight of the CUMS-induced
model groups was decreased without signiﬁcant difference among
groups [F(2,24)¼3.448, n.s.]. However, body weight of olfactory
bulbectomy-induced model groups was still increased slightly
after the operation. After 4 weeks of chronic treatment, body
weight of all the groups was increased. Among them, body weight
of the stressþvanillin, stressþﬂuoxetine and control groups was
increased signiﬁcantly compared with those of post-model within
the group [F(4,41)¼11.15, Po0.01; F(4,41)¼8.514, P¼0.022;
F(4,46)¼26.783, Po0.01, respectively](see Table 1).
After the CUMS procedure, the serum corticosterone was
signiﬁcantly higher than before [F(3,89)¼14.16, Po0.01]. No
similar result was found in the bulbectomyþvanillin and control
groups when compared with the pre-model data (see Fig.2).
3.2. Vanillin decreased immobility time in the FST
Immobility time was homogeneous among pre-model animals.
After the CUMS procedure (or operation), immobility time was
noticeably increased except for the control group. No signiﬁcant
difference was found among the groups after CUMS procedure
[F(2,24)¼3.486, n.s.]. Following antidepressant treatment for
4 weeks, immobility time in the stressþvanillin and stressþﬂuox-
etine groups was signiﬁcantly decreased [F(4,42)¼34.73, Po0.01;
F(4,42)¼13.55, Po0.01, respectively]. However, in the bulbecto-
myþvanillin group, no similar effect was found (see Table 2).
3.3. Vanillin increased sucrose consumption
Before modeling, sucrose consumption was similar among the
groups. However, CUMS procedure signiﬁcantly decreased sucrose
consumption. The bulbectomyþvanillin group was similarly affected.
No remarkable difference was found among CUMS-induced model
groups [F(2,24)¼2.168, n.s.]. Treatment with vanillin or ﬂuoxetine
remarkably alleviated the decrease in sucrose consumption in CUMS
model animals [F(4,42)¼12.32, Po0.01; F(4,42)¼5.65, Po0.01,
respectively]. However, vanillin aromatherapy had no effect on
sucrose consumption in the bulbectomyþvanillin group with the
disrupted olfactory pathway (see Table 3).
3.4. Monoamine neurotransmitters in the rat brain
In this study, monoamine neurotransmitter levels were pre-
sented as relative values of the monoamine neurotransmitters
and the total protein. In CUMS model rats, 5-HT level in the
stressþvanillin and stressþﬂuoxetine groups was signiﬁcantly
increased when compared with the stress group [F(4,42)¼4.846,
P¼0.030; F(4,42)¼4.846, P¼0.036, respectively], whereas NE in the
two groups was elevated but not signiﬁcantly [F(4,42)¼6.977, n.s.].
DA was signiﬁcantly increased in the stressþvanillin group com-
pared with the stress group [F(4.42)¼6.174, P¼0.041]. However, for
the stressþﬂuoxetine group, DA was increased but not signiﬁcantly
[F(4.42)¼6.174, n.s.]. In the bulbectomyþvanillin group, after vanil-
lin aromatherapy for 4 weeks, 5-HT, NE, DA were still dramatically
lower than the control group [F(4,42)¼4.846, P¼0.037; F(4,42)¼
6.977,Po0.01; F(4,42)¼6.174, Po0.01, respectively] (see Table 4).
4. Discussion
The present study was designed to assess the effect of a positive
odor (vanillin) on mood in rodents since they share similar olfactory
perception with humans (Mandairon et al., 2009). Pleasant olfactory
stimuli, such as rose, orange, citrus, lemon and lavender odors, can
be experienced as extremely relaxing and calming (Komori et al.,
1995a, 1995b; Umezu et al., 2002; Zald, 2003; Almeida et al., 2004;
Lehrner et al., 2005; Bradley et al., 2007; Matsukawa et al., 2011). In
many countries, aromatherapy is increasingly becoming a beneﬁcial
supplement to mainstream treatments for postpartum depression,
especially when considering safety of drug treatment (Weier and
Beal, 2004; Cavanagh and Wilkinson, 2002). Some researches into
complementary therapies for the treatment of depression have
revealed that odorant aromatherapy can act on the central nervous
system, relieving depression and anxiety, relaxing and restoring
both physical and emotional well-being (Motomura et al., 2001;
Edge, 2003). It has been veriﬁed by fMRI that the limbic structures
are involved in both olfactory and emotional processing (Royet
et al., 2003; Stöcker et al., 2006). The close relationship between
olfaction and emotions is a logical consequence of how both
processes share several limbic regions (Zald and Pardo, 1997). In
this study, we aimed to validate the hypothesis that vanillin, a
pleasant odor, would combat depressive symptoms and modulate
emotions in MDD via olfactory pathway.
The CUMS procedure is a classic method for inducing depressive
disorder in animals andmimics the stressful events common in human
society. A prominent mechanism by which the brain reacts to stress is
by activation of the hypothalamic–pituitary–adrenal (HPA) axis. It is
also possible that a sign of hyper function of the HPA is peripheral
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glucocorticoid (corticosterone in animals) elevation, which mediates
damage to the brain and subsequent behavioral changes (Strome et al.,
2002; Nestler,et al., 2002). In this study, serum corticosterone as well
as other behavioral parameters was used to assess the animal
model. After the CUMS procedure, FST, SCT and the serum corti-
costerone in particular were signiﬁcantly different compared with
those of pre-CUMS states (Tables 2 and 3; Fig. 2). Body weight was
also decreased as expected after CUMS (Table 1). Although there
was slight difference among body weight after CUMS procedure,
neither signiﬁcant difference among groups nor obvious inﬂuence
on other behaviors was found. It was clear that the animal model of
depression was established successfully by this procedure. Another
documented method for establishing depressive disorder model is
olfactory bulbectomy. In our study, the procedure was used to
destroy the olfactory pathway and served as a veriﬁcation to
demonstrate that vanillin would be ineffective on the depression-
like behaviors of animals without an intact olfactory pathway. Given
that the rats would develop more serious syndromes when the
olfactory bulbectomy operation was practiced on CUMS model
animals, we used normal animals instead. In the bulbectomyþ
vanillin group and the control group, no signiﬁcant corticosterone
change was found. Similar result was also reported in a previous
study (Jaako-Movits,et al.,2006). By comparing the behavioral
parameters within groups (post-operation vs pre-operation) and
between groups (the bulbectomyþvanillin group vs the control
group), we conﬁrmed that the olfactory bulbectomy-induced
depressive model was established (Tables 2 and 3). This was also
conﬁrmed by the subsequent neurotransmitter analyses (Table 4).
In this study, the two methods were supplementary to each other.
Our data show that the body weight of all groups was increased
during chronic treatment with the increase in the stressþvanillin
group being the largest (Table 1). Even so, we need to be cautious
in interpreting this as a sign of improvement, because vanillin is a
kind of milky odorant that may stimulate the appetite of rats.
Immobility time in the FST is an index of behavioral despair and
antidepressant drugs are able to reduce the time spent in this posture
(Dalvi and Lucki, 1999; Cryan et al., 2002). Its predictive validity is so
high that if a treatment reduces immobility time, it suggests that it
has an antidepressive effect (Cryan et al., 2002). Another essential
parameter is consumption of sucrose in the SCT. A lower level of
sucrose consumption or sucrose preference in stressed animals has
been interpreted as a marker of anhedonia, which is a core symptom
of depressionwhen interest in pleasurable and rewarding experiences
is lost (Willner et al., 1992; Muscat et al., 1990). After chronic
treatment, both immobility time and sucrose consumption were
reversed to normal in the stressþvanillin group and stressþﬂuox-
etine group. However, no obvious improvement was found in the
bulbectomyþvanillin group. Previous research has reported that
depression-like behaviors of bulbectomized rats not exposed to active
treatment during the 4–6 weeks after surgery remained unimproved
(Megan et al., 2007). It seems that an intact olfactory pathway is
necessary for the anti-depressant effect of vanillin.
The mechanisms of behavioral variation induced by odors
involves the expression of cholecystokinin mRNA in the mesocor-
ticolimbic pathway and amygdala activation (Hebb et al., 2002;
Zald and Pardo, 1997). In this study, monoamine neurotransmitters
were analyzed preliminarily since they may be the main patholo-
gical mechanisms in the occurrence and development of MDD.
Depletion of monoamine neurotransmitters leads to depressive
disorder, whereas almost every compound synthesized for the
Fig. 2. Changes of serum corticosterone before and after model (unit: nmol/l).
Note: The presented data are meanþS.E.M. Statistical analysis was carried out by
one way ANOVA. **Po0.01 vs pre-model.
Table 2
Changes of immobility time in the FST at different time points (unit: s).
Groups Pre-model Post-model 4w
Stressþvanillin 30.9976.11 67.0775.15nn 19.5673.59△△
Stressþﬂuoxetine 24.5775.31 59.30712.30n 18.9274.30△△
Stress 27.3275.03 68.1177.64nn 51.0073.51
Bulbectomyþvanillin 24.7071.83 98.80717.78nn 94.3075.33
Control 19.1671.02 30.8574.72 17.7172.38
n o0.05 Compared with the pre-model within the group;
nn o0.01 Compared with the pre-model within the group;
△△ o0.01 Compared with the post-model within the group.
Table 3
Change of sucrose consumption in SCT at different time points (unit: g).
Groups Pre-model Post-model 4w
Stressþvanillin 88.8777.89 55.0077.82n 93.9074.84△△
Stressþﬂuoxetine 83.1377.28 59.7276.22n 88.5076.12△△
Stress 91.7576.26 49.1776.32n 60.5074.12
Bulbectomyþvanillin 93.2575.71 46.6377.95nn 45.0075.05
Control 94.5075.09 78.33710.27 75.3778.36
n o0.05 Compared with the pre-model within the group
nn o0.01 Compared with the pre-model within the group.
△△ o0.01 Compared with the post-model within the group.
Table 1
Measurement of body weight at different time points in the groups (unit: g).
Groups Pre-model Post-model 2w 3w 4w
Stressþvanillin 226.4376.06 221.14713.90 245.86711.36 270.86719.57nn 293.71721.07nn
Stressþﬂuoxetine 235.3775.83 223.6375.38 262.50721.37 284.87723.09n 287.87728.03n
Stress 235.6374.04 210.1376.63 224.37719.94 239.75716.73 240.62716.53
Bulbectomyþvanillin 234.76710.59 249.5079.48 257.7779.98 262.06718.93 268.1978.07
control 225.7575.19 240.1877.44 262.6779.04nn 266.61711.18nn 275.0179.61nn
n o0.05 Compared with the post-model within the group.
nn o0.01 Compared with the post-model within the group.
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purpose of increasing monoamine neurotransmitter levels has
proven to be a clinically effective antidepressant (Belmaker and
Agam, 2008). In this study, 5-HT and DA in brain tissue homo-
genate were found elevated in the stressþvanillin group (Table 4).
This result was in line with the anti-stress effect observed with
lemon oil modulating 5-HT and DA activity (Komiya et al., 2006).
However, no similar result was found in the bulbectomyþvanillin
group after 4 weeks of vanillin aromatherapy.
The data from the present study have revealed that depression-
like behaviors can be reversed by chronic vanillin aromatherapy.
One possible assumption is that the volatile compound can act
pharmacologically by entering in the blood stream by way of the
nasal or lung mucosa. This effect depends on the concentration of
the compound (Herz, 2009). However, in our study, it is difﬁcult to
meet the requirement with current intensity of vanillin. The other
possibility is by the olfactory pathway. Buck and Axel (1991) have
interpreted the basic operating principles of olfaction. They
demonstrated that an odorant would bind to the receptor of an
olfactory sensory neuron (OSN) and induce an action potential. It is
the nerve impulse evoked rather than the odorant itself that is
transmitted to the olfactory projection centers. Moreover, odorant
signaling cascade is produced during the transduction of neural
signal so that odorant can be detected at minute concentrations
(Bozza et al., 2002). After considering comprehensively, we would
like to prefer the later.
The olfactory nerve is the only cranial nerve connected to the
tenecephanon. The projection centers are extensive and most of
them is shared with emotional centers. So, the olfaction may be a
convenient, safe pathway for treating MDD. As far as odor concen-
tration is concerned, the medium intensity of vanillin used is
appropriate since it can be perceived by depressive patients for
whom the threshold concentration of pleasant odors is elevated
while hedonic valence remains unchanged (Pause et al., 2001).
Olfactory perception has another phenomenon known as the
adaptation effect. Here, to avoid olfactory adaptation during vanillin
aromatherapy, a protocol of repeated exposes was adopted.
What these ﬁndings seem to highlight is that odorants with
positive hedonic qualities may serve as potential antidepressants
via olfactory pathway. The underlying mechanisms may be related
to the modulation of monoamine neurotransmitters in brain.
Certainly, there were some limitations in determination of mono-
amine neurotransmitters in whole brain. In further studies, mono-
amines levels will be examined in some brain regions of interest:
the amygdala, the hippocampus, the prefrontal cortex and others
involved in emotional processing as well as olfaction function.
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